Evidence map›Paper›PMID 37234340›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

Healthcare professionals' awareness, attitudes and practices towards pharmacovigilance and spontaneous adverse drug reaction reporting in Jazan Province, Saudi Arabia: A survey study.

Saad S Alqahtani, Sarfaraz Ahmad, Nawazish Alam, Nabeel Kashan Syed, Mamoon H Syed, Amani Khardali, Ayesha Yasmeen, Ali M Alshahrani, Abdulaziz I Alzarea, Abdullah S Alanazi and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Saad S AlqahtaniDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Sarfaraz AhmadDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Nawazish AlamDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Nabeel Kashan SyedDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Mamoon H SyedDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Amani KhardaliDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Ayesha YasmeenDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Ali M AlshahraniDepartment of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Abdulaziz I AlzareaDepartment of Clinical Pharmacy, College of Pharmacy, Jouf University Sakaka, Saudi Arabia.
Abdullah S AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, Jouf University Sakaka, Saudi Arabia.
Mohamed Hassan ElnaemSchool of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, BT52, ISA, United Kingdom.
Jazan University · SAAl Jouf University · SAKing Khalid University · SATaif University · SAUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Globally, adverse drug reactions (ADRs) are the foremost cause of morbidity as well as mortality. This necessitates a system of surveillance that can effectively and efficiently monitor the effect of drugs on the general population. The role of pharmacovigilance (PV) is paramount in ensuring drug safety through spontaneous ADR reporting. Methods: Data collection in the current research was carried out by an anonymous, online 36-item self-report questionnaire amongst a sample of 351 working healthcare professionals (HCPs) across different regions of Jazan Province, Kingdom of Saudi Arabia (KSA). The current sample comprised 54.4% males and 45.6% females, having an age range of 26-57 years, and was conducted between August 21 and October 21, 2022. Participants were recruited using the convenience snowball sampling technique. Results: The participants' awareness of PV as well as spontaneous ADR reporting, had a significant association with having <40 years of age ( Conclusion: Our results demonstrate a need for designing and conducting educational programs, providing training and conducting workshops for all the HCPs to improve their awareness towards PV and spontaneous ADR reporting while also highlighting the need and importance of having positive attitudes towards spontaneous ADR reporting. Cooperation between different HCPs should be encouraged to improve their practices towards spontaneous ADR reporting.

Indexed as

AttitudesAwarenessHealthcare professionalsKingdom of Saudi ArabiaPharmacovigilancePracticesSpontaneous adverse drug reaction reporting

Identifiers

PMID37234340
PMCPMC10205759
OpenAlexW4366982067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.